NCT04653168View on ClinicalTrials.gov

A Study of LY3041658 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 7, 2020

Primary Completion Date

May 28, 2021

Study Completion Date

May 28, 2021

Conditions
Healthy
Interventions
DRUG

LY3041658

Administered SC

Trial Locations (1)

138623

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04653168 - A Study of LY3041658 in Healthy Participants | Biotech Hunter | Biotech Hunter